...
首页> 外文期刊>International immunopharmacology >Total glucosides of paeony inhibit the inflammatory responses of mice with allergic contact dermatitis by restoring the balanced secretion of pro-/anti-inflammatory cytokines
【24h】

Total glucosides of paeony inhibit the inflammatory responses of mice with allergic contact dermatitis by restoring the balanced secretion of pro-/anti-inflammatory cytokines

机译:白eon总苷通过恢复促炎/抗炎细胞因子的平衡分泌,抑制过敏性接触性皮炎小鼠的炎症反应

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The present study aimed to investigate the regulation exerted by the total glucosides of paeony (TGP) on the production of interleukin-2 (IL-2), IL-4, IL-10 and IL-17 in the serum and lymphocytes of mice with allergic contact dermatitis (ACD). ACD in mice was induced by the repeated application of 2,4-dinitrochlorobenzene (DNCB) to their skins. The mice were orally administered TGP (35, 70, and 140 mg/kg/d) and prednisone (Pre, 5 mg/kg/d) from day 1 to day 7 after immunization. The inflammatory responses were evaluated by ear swelling and histological examination. Thymocyte proliferation was assayed by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H tetrazolium bromide assay. The cytokine production in the serum and lymphocytes supernatant was measured by enzyme-linked immunosorbent assay. The results indicated that the topical application of DNCB to the skin provoked obvious inflammatory responses. The oral administration of TGP (70 and 140 mg/kg/d) and Pre (5 mg/kg/d) significantly inhibited skin inflammation, decreased the thymus and spleen indices, and inhibited thymocyte proliferation in mice treated with DNCB. Further study indicated that TGP increased IL-4 and IL-10 production but decreased the production of IL-2 and IL-17 in the serum and lymphocyte supernatant The correlation analysis suggested significantly positive correlations between IL-2 and IL-17 production and the severity of skin inflammation, whereas negative correlations were obtained for IL-4 and IL-10 production and skin inflammation. In summary, these results suggest that the therapeutic effects of TGP on ACD may result from its regulation of the imbalanced secretion of IL-2/IL-4 and IL-10/IL-17. (C) 2014 Elsevier B.V. All rights reserved.
机译:本研究旨在探讨白eon总苷(TGP)对高脂血症小鼠血清和淋巴细胞中白介素2(IL-2),IL-4,IL-10和IL-17产生的调节作用。过敏性接触性皮炎(ACD)。通过在皮肤上重复使用2,4-二硝基氯苯(DNCB)诱导小鼠ACD。在免疫后第1天至第7天,给小鼠口服TGP(35、70和140mg / kg / d)和泼尼松(Pre,5mg / kg / d)。通过耳朵肿胀和组织学检查评估炎症反应。通过3-(4,5-二甲基噻唑-2-基)-2,5-二苯基-2H溴化四氮唑测定法检测胸腺细胞的增殖。通过酶联免疫吸附测定法测定血清和淋巴细胞上清液中的细胞因子产生。结果表明,DNCB在皮肤上的局部应用引起明显的炎症反应。在经DNCB处理的小鼠中,口服TGP(70和140 mg / kg / d)和Pre(5 mg / kg / d)可显着抑制皮肤炎症,降低胸腺和脾脏指数,并抑制胸腺细胞增殖。进一步的研究表明,TGP可增加血清和淋巴细胞上清液中IL-4和IL-10的产生,但降低IL-2和IL-17的产生。相关分析表明IL-2和IL-17的产生与血清中IL-2和IL-17的产生呈显着正相关。皮肤炎症的严重性,而IL-4和IL-10的产生与皮肤炎症却呈负相关。总之,这些结果表明,TGP对ACD的治疗作用可能是由于其调节IL-2 / IL-4和IL-10 / IL-17分泌失衡所致。 (C)2014 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号